You are here

Article info

Article menu
Download PDFPDF
Clinical and epidemiological research
Concise report
On-demand anakinra treatment is effective in mevalonate kinase deficiency

Authors

  1. Correspondence to Simon Anna, Department of General Internal Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands; a.simon{at}aig.umcn.nl
View Full Text

Citation

Bodar EJ, Kuijk LM, Drenth JPH, et al
On-demand anakinra treatment is effective in mevalonate kinase deficiency
Annals of the Rheumatic Diseases 2011;70:2155-2158.

Publication history

  • Accepted June 17, 2011
  • First published August 21, 2011.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions